Loxoribine
- Product Name
- Loxoribine
- CAS No.
- 121288-39-9
- Chemical Name
- Loxoribine
- Synonyms
- RWJ 21757;Loxoribine;Loxoribine, 10 mM in DMSO;7,8-Dihydro-8-oxo-7-allyl-guanosine;7-Allyl-7,8-dihydro-8-oxoguanosine 95%;7-ALLYL-7 8-DIHYDRO-8-OXOGUANOSINE 95;7,8-Dihydro-8-oxo-7-(2-propenyl)guanosine;Guanosine, 7,8-dihydro-8-oxo-7-(2-propenyl)-;7,8-dihydro-8-oxo-7-allyl-guanosine, Loxoribine;Guanosine, 7,8-dihydro-8-oxo-7-(2-propen-1-yl)-
- CBNumber
- CB7499469
- Molecular Formula
- C13H17N5O6
- Formula Weight
- 339.3
- MOL File
- 121288-39-9.mol
Loxoribine Property
- Melting point:
- 227-230 °C(lit.)
- Density
- 1.92±0.1 g/cm3(Predicted)
- storage temp.
- Desiccate at +4°C
- solubility
- Soluble in DMSO (up to 25 mg/ml).
- form
- White to off-white solid.
- pka
- 10.29±0.20(Predicted)
- color
- White
- optical activity
- [α]21/D 32°, c = 1 in H2O
- Stability:
- Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 3 months.
Safety
- WGK Germany
- 3
- HS Code
- 29349990
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Warning
- Hazard statements
-
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
- Precautionary statements
-
P261Avoid breathing dust/fume/gas/mist/vapours/spray.
P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
N-Bromosuccinimide Price
- Product number
- 496812
- Product name
- 7-Allyl-7,8-dihydro-8-oxoguanosine
- Purity
- 95%
- Packaging
- 50mg
- Price
- $200.34
- Updated
- 2025/07/31
- Product number
- 496812
- Product name
- 7-Allyl-7,8-dihydro-8-oxoguanosine
- Purity
- 95%
- Packaging
- 250mg
- Price
- $496
- Updated
- 2025/07/31
- Product number
- 21186
- Product name
- Loxoribine
- Purity
- ≥98%
- Packaging
- 5mg
- Price
- $32
- Updated
- 2024/03/01
- Product number
- 21186
- Product name
- Loxoribine
- Purity
- ≥98%
- Packaging
- 10mg
- Price
- $61
- Updated
- 2024/03/01
- Product number
- 21186
- Product name
- Loxoribine
- Purity
- ≥98%
- Packaging
- 25mg
- Price
- $86
- Updated
- 2024/03/01
Loxoribine Chemical Properties,Usage,Production
Description
Loxoribine is a guanosine derivative and an agonist of toll-like receptor 7 (TLR7). It is selective for TLR7 over other human TLRs in a cell-based reporter assay at 1 mM.. Loxoribine induces proliferation, increases the antibody response to sheep red blood cells, and activates natural killer cell activity against Yac-1 lymphoma cells in murine splenocyte cultures (EC50s = 10-50, 3-20, and 13-22 μM, respectively). Loxoribine (250 μM) increases production of IL-12, IL-23, IL-27, and IL-10 by human monocyte-derived dendritic cells (MoDCs). Loxoribine-treated MoDCs induce higher levels of IL-17 and IFN-γ secretion by co-cultured allogeneic CD4+ T cells compared to control MoDCs. Loxoribine (120 mg/kg) reduces the number of pulmonary metastases in the B16 mouse model of melanoma, an effect enhanced by co-administration of IL-2, and exhibits adjuvant activity in mice immunized with a B16 tumor vaccine.
Chemical Properties
White Solid
Uses
7-Allyl-7,8-dihydro-8-oxoguanosine (Loxoribine) is a small-molecule immunostimulant. Loxoribine is a toll-like receptor 7 (TLR7) agonist; induces immune cell activation and increases cytokine product ion. Loxoribine displays antitumor and antiviral activity in various animal models.
Uses
Loxoribine is a selective toll-like receptor 7 (TLR7) agonist that activates immune cells and increases cytokine production.
Uses
Small-molecule immunostimulants
Biological Activity
Toll-like receptor 7 (TLR7) agonist; induces immune cell activation and increases cytokine production. Displays antitumor and antiviral activity in various animal models.
in vivo
Loxoribine (2 mg; s.c.or i.v.) activates murine natural killer (NK) cells in vivo[3].
| Animal Model: | 8-12 weeks male CBA/J mice[3] |
| Dosage: | 2 mg |
| Administration: | Subcutaneous or intravenous injection |
| Result: | activates murine natural killer (NK) cells in vivo. |
IC 50
TLR7
References
[1] FLORIAN HEIL. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily[J]. European Journal of Immunology, 2003, 33 11: 2987-2997. DOI:10.1002/eji.200324238
[2] GOODMAN M G. A new approach to vaccine adjuvants. Immunopotentiation by intracellular T-helper-like signals transmitted by loxoribine.[J]. Pharmaceutical biotechnology, 1995, 6: 581-609.
[3] MARÍA V GIRART. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.[J]. Journal of immunology, 2007, 179 6: 3472-3479. DOI:10.4049/jimmunol.179.6.3472
[4] CAMERON R STEWART. Toll-like receptor 7 ligands inhibit influenza A infection in chickens.[J]. Journal of Interferon and Cytokine Research, 2012, 32 1: 46-51. DOI:10.1089/jir.2011.0036
[5] CHENCHEN WANG. The TLR7 agonist induces tumor regression both by promoting CD4⁺T cells proliferation and by reversing T regulatory cell-mediated suppression via dendritic cells.[J]. Oncotarget, 2015: 1779-1789. DOI:10.18632/oncotarget.2757
Loxoribine Preparation Products And Raw materials
Raw materials
Preparation Products
Loxoribine Suppliers
- Tel
- 888-539-0666
- Fax
- 888-539-0666
- info@emmx.com
- Country
- United States
- ProdList
- 8447
- Advantage
- 60
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Country
- United States
- ProdList
- 32435
- Advantage
- 58
- Tel
- +1-631-485-4226
- Fax
- 1-631-614-7828
- inquiry@bocsci.com
- Country
- United States
- ProdList
- 19552
- Advantage
- 58
- Tel
- --
- Fax
- --
- sales@apexbt.com
- Country
- United States
- ProdList
- 6251
- Advantage
- 58
- Tel
- 16314854226
- info@bocsci.com
- Country
- United States
- ProdList
- 9923
- Advantage
- 65
- Tel
- --
- Fax
- --
- sales@focusbiomolecules.com
- Country
- United States
- ProdList
- 1284
- Advantage
- 58
- Tel
- --
- Fax
- --
- us.orders@abcam.com
- Country
- United States
- ProdList
- 6001
- Advantage
- 50
- Tel
- --
- Fax
- --
- cayman@caymanchem.com
- Country
- United States
- ProdList
- 6213
- Advantage
- 81
- Tel
- --
- Fax
- --
- chemicals@usbio.net
- Country
- United States
- ProdList
- 6214
- Advantage
- 80
- Tel
- --
- Fax
- --
- sales@medchemexpress.com
- Country
- United States
- ProdList
- 6398
- Advantage
- 58
- Tel
- --
- Fax
- --
- Country
- United States
- ProdList
- 6773
- Advantage
- 87
- Tel
- --
- Fax
- --
- sales@anviachem.com
- Country
- United States
- ProdList
- 3933
- Advantage
- 0
- Tel
- --
- Fax
- --
- stohler@medicalisotopes.com
- Country
- United States
- ProdList
- 6181
- Advantage
- 68
- Tel
- --
- Fax
- --
- sales@2apharmachem.com
- Country
- United States
- ProdList
- 6137
- Advantage
- 39
- Tel
- --
- Fax
- --
- sales@3bsc.com
- Country
- United States
- ProdList
- 6718
- Advantage
- 47